AlloVir, Inc.
ALVR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $398 | $2,565 | $1,117 |
| Gross Profit | $0 | -$398 | -$2,565 | -$1,117 |
| % Margin | – | – | – | – |
| R&D Expenses | $12,340 | $132,672 | $118,870 | $120,735 |
| G&A Expenses | $42,916 | $48,261 | $52,332 | $49,083 |
| SG&A Expenses | $42,916 | $48,261 | $52,332 | $49,083 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $10,185 | $0 | $0 | -$1,117 |
| Operating Expenses | $65,441 | $180,933 | $171,202 | $168,701 |
| Operating Income | -$65,441 | -$181,331 | -$171,202 | -$169,818 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $6,672 | -$9,213 | $2,227 | -$1,137 |
| Pre-Tax Income | -$58,769 | -$190,544 | -$168,975 | -$170,955 |
| Tax Expense | $0 | -$126 | -$265 | $1,007 |
| Net Income | -$58,769 | -$190,418 | -$168,710 | -$171,962 |
| % Margin | – | – | – | – |
| EPS | -11.73 | -42.09 | -50.6 | -63.02 |
| % Growth | 72.1% | 16.8% | 19.7% | – |
| EPS Diluted | -11.73 | -42.09 | -50.6 | -63.02 |
| Weighted Avg Shares Out | 4,962 | 4,474 | 3,296 | 2,700 |
| Weighted Avg Shares Out Dil | 4,962 | 4,474 | 3,296 | 2,700 |
| Supplemental Information | – | – | – | – |
| Interest Income | $5,486 | $5,734 | $1,876 | $1,315 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $398 | $2,565 | $1,117 |
| EBITDA | -$65,441 | -$190,146 | -$166,410 | -$169,838 |
| % Margin | – | – | – | – |